Domů › Rakovina vaječníků › Connecticut › New Haven
Klinické studie Rakovina vaječníků v New Haven, CT
21 studií pro Rakovina vaječníků hledá účastníky v lokalitách v New Haven a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Probíhá náborFáze 2/3
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · Vzdálenost 7 mi
- Smilow Cancer Hospital-Derby Care Center, Derby · Vzdálenost 8 mi
- a dalších 1
A Study of PHST001 in Advanced Solid Tumors
Probíhá náborFáze 1
- Yale Cancer Center, New Haven
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Probíhá náborFáze 1/2
- Yale Cancer Center, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 2
- Yale Cancer Center, New Haven
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Probíhá náborFáze 1
- Yale University - Yale University School of Medicine, New Haven
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Probíhá náborFáze 2
- Yale University School of Medicine /ID# 275794, New Haven
Study of AVZO-021 in Patients With Advanced Solid Tumors
Probíhá náborFáze 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Probíhá náborFáze 1
- Yale University, Yale Cancer Center, New Haven
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Probíhá náborFáze 1/2
- Yale Cancer Center, New Haven
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Probíhá náborFáze 3
- Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0001), New Haven
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Probíhá náborFáze 1
- Normunity Investigational Site, New Haven
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Probíhá nábor
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Probíhá náborFáze 3
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Probíhá náborFáze 2/3
- Yale University School of Medicine, New Haven
Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer
Probíhá nábor
- Yale University, New Haven
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
Probíhá náborFáze 1
- Yale University, New Haven
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Probíhá náborFáze 1/2
- Yale University, Yale Cancer Center, New Haven
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Probíhá náborFáze 3
- Smilow Cancer Hospital at Yale- New Haven, New Haven
- Yale University School of Medicine, New Haven
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Probíhá náborFáze 1/2
- Yale University, Yale Cancer Center, New Haven
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Probíhá náborFáze 1
- Yale University, New Haven
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Probíhá náborFáze 2
- Smilow Cancer Hospital at Yale - New Haven, New Haven
Studie Rakovina vaječníků v jiných městech
- Houston, TX89 studií
- New York City, NY69 studií
- Boston, MA61 studií
- Los Angeles, CA50 studií
- Nashville, TN49 studií
- Arlington, VA46 studií
- Philadelphia, PA44 studií
- Columbus, OH39 studií
- St. Louis, MO38 studií
- Chicago, IL36 studií
- San Antonio, TX31 studií
- Cleveland, OH30 studií
Další studie v New Haven
- Nemalobuněčný plicní karcinom41 studií
- Rakovina prsu38 studií
- Rakovina (všechny typy)33 studií
- Metastatický karcinom23 studií
- Rakovina plic22 studií
- Squamózní buněčný karcinom hlavy a krku22 studií
- Kolorektální karcinom20 studií
- Rakovina prostaty20 studií
- Akutní myeloidní leukemie17 studií
- Porucha užívání alkoholu (AUD)17 studií
- Předávkování opioidy17 studií
- Rakovina slinivky břišní16 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.